EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis

Chuyu Wu, Meiling Jiang, Xue Yang, Yixuan Liu, Bin Huang, Yi Guo, Runjing Cao, Zhihui Cui, Guozhen Deng, Weiyan Wang, Mengdi Guo, Zhiyong Lin und 6 weitere

Journal of Clinical Investigation · 15.10.2025 · 135 (20)

DOI: 10.1172/jci195214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.10.2025. Verfasst von Chuyu Wu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu,…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Encephalomyelitis, Autoimmune, Experimental, Th17 Cells, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China for Excellent Young Scholars, The Innovation and Entrepreneurial Team of Sichuan Tianfu Emei Program, Funding for Distinguished Young Scholars of Sichuan Provincial People’s Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a progressive, chronic, and highly disabling neuroinflammatory disorder characterized by demyelination and T cell–driven inflammation. Pathogenic T cells play a central role in MS, but effective therapeutic targeting remains challenging. Here, we identified ankyrin repeat domain–containing protein 55 (ANKRD55) as a key regulator of T cell function by single-cell transcriptomic analysis of cerebrospinal fluid and blood from MS patients. ANKRD55 was predominantly expressed in CD4 + T cells in both compartments. Genetic ablation of Ankrd55 led to a robustly reduced disease severity and neuroinflammation in experimental autoimmune encephalomyelitis (EAE), a widely used animal model for MS. Furthermore, T cell–specific deficiency of Ankrd55 significantly impaired Th1 polarization and Th17 differentiation, reducing EAE pathogenicity. Mechanistically, we found that Ankrd55 deficiency disrupted T cell receptor (TCR) signaling integrity. We demonstrated that ANKRD55 regulates the formation of the immune synapse, an essential prerequisite for TCR activation, by interacting with subunits of the chaperonin-containing TCP1 (CCT) complex and modulating its activity, enhancing its assembly by competing with CCT5 for binding to TCP1, CCT3, and CCT6. This facilitates proper microtubule organization and TCR activation. These findings establish ANKRD55 as a critical regulator of TCR signaling and highlight its therapeutic potential in pathogenic T cell–driven autoimmune diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisEncephalomyelitis, Autoimmune, ExperimentalTh17 CellsCD4-Positive T-LymphocytesTh1 CellsAnimalsHumansMiceInflammationMice, KnockoutFemaleReceptors, Antigen, T-CellSignal TransductionMaleChaperonin Containing TCP-1

Stichwörter der Autor:innen

Autoimmune diseasesAutoimmunityImmunologyMultiple sclerosisT cell receptor

Substanzen

Receptors, Antigen, T-CellChaperonin Containing TCP-1

Autor:innen und Institutionen

  • Department of Neurology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Department of Science and Technology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Center for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Chi…
  • Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China.
  • Sichuan Medical Laboratory Clinical Medical Research Center, Sichuan Provincial People's Hospital, Chengdu, China.

Förderung

  • National Natural Science Foundation of China for Excellent Young Scholars
  • The Innovation and Entrepreneurial Team of Sichuan Tianfu Emei Program
  • Funding for Distinguished Young Scholars of Sichuan Provincial People’s Hospital
  • Funding for Distinguished Young Scholars of University of Electronic Science and Technology of China
  • National Natural Science Foundation of China

Zitieren

APA

Wu, C., Jiang, M., Yang, X., Liu, Y., Huang, B., Guo, Y., Cao, R., Cui, Z., Deng, G., Wang, W., Guo, M., Lin, Z., Fan, J., Zhang, L. M., Di Cesare Mannelli, L., Pang, T., Wang, C., & Zhang, C. J. (2025). ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis. Journal of Clinical Investigation, 135(20). https://doi.org/10.1172/jci195214

Vancouver

Wu C, Jiang M, Yang X, Liu Y, Huang B, Guo Y, et al. ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis. Journal of Clinical Investigation. 2025;135(20). doi:10.1172/jci195214

BibTeX
@article{Wu2025,
  author = {Wu, Chuyu and Jiang, Meiling and Yang, Xue and Liu, Yixuan and Huang, Bin and Guo, Yi and Cao, Runjing and Cui, Zhihui and Deng, Guozhen and Wang, Weiyan and Guo, Mengdi and Lin, Zhiyong and Fan, Jiahui and Zhang, Lin-Ming and Di Cesare Mannelli, Lorenzo and Pang, Tao and Wang, Chenhui and Zhang, Cun-Jin},
  title = {ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {20},
  doi = {10.1172/jci195214}
}
Kostenlos starten →